UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials

The lancet oncology, 2010-03, Vol.11 (3), p.231-240

2010

Volltextzugriff (PDF)

One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

Health technology assessment (Winchester, England), 2023-11, Vol.27 (25), p.1-176

2023

Volltextzugriff (PDF)

TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells

Scientific reports, 2021-03, Vol.11 (1), p.7119-7119, Article 7119

2021

Volltextzugriff (PDF)

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

The Lancet (British edition), 2020-05, Vol.395 (10237), p.1613-1626

2020

Volltextzugriff (PDF)

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer

Journal of clinical oncology, 2020-10, Vol.38 (28), p.3261-3272

2020

Volltextzugriff (PDF)

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

The Lancet (British edition), 2017-09, Vol.390 (10099), p.1048-1060

2017

Volltextzugriff (PDF)

Voluntary breath-hold technique for reducing heart dose in left breast radiotherapy

Journal of visualized experiments, 2014-07 (89)

2014

Volltextzugriff (PDF)

Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis

Breast cancer research and treatment, 2023, Vol.197 (2), p.405-416

2023

Volltextzugriff (PDF)

Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial

Journal of clinical oncology, 2019-02, Vol.37 (4), p.305-317

2019

Volltextzugriff (PDF)

Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial

The lancet oncology, 2006-06, Vol.7 (6), p.467-471

2006

Volltextzugriff (PDF)

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial

The Lancet (British edition), 2023-06, Vol.401 (10394), p.2124-2137

2023

Volltextzugriff (PDF)

The UK HeartSpare Study (Stage IB): Randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery

Radiotherapy and oncology, 2015-01, Vol.114 (1), p.66-72

2015

Volltextzugriff (PDF)

Targeted Intraoperative Radiotherapy for Early Breast Cancer

JAMA oncology, 2020-10, Vol.6 (10), p.1636

2020

Volltextzugriff (PDF)

Targeted radiotherapy for early breast cancer – Authors' reply

The Lancet (British edition), 2018-01, Vol.391 (10115), p.27-28

2018

Volltextzugriff (PDF)

Shorter fractionation schedules in breast cancer radiotherapy: Clinical and economic implications

European journal of cancer (1990), 2009-03, Vol.45 (5), p.730-731

2009

Volltextzugriff (PDF)

Ductal carcinoma in situ of the breast

BMJ, 2012-02, Vol.344 (feb29 1), p.e797-e797

International edition, 2012

Volltextzugriff (PDF)

Late effects of breast radiotherapy

The Lancet (British edition), 2014-04, Vol.383 (9926), p.1383-1384

2014

Volltextzugriff (PDF)

Hypofractionated Radiotherapy for Breast Cancer

The New England journal of medicine, 2010-05, Vol.362 (19), p.1843-1844

2010

Volltextzugriff (PDF)

Genome‐wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c‐Kit, CD117) and oestrogen receptor‐α (ERα) in response to therapeutic radiation

The Journal of pathology, 2009-09, Vol.219 (1), p.131-140

2009

Volltextzugriff (PDF)

Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?

Journal of clinical oncology, 2009-02, Vol.27 (6), p.996-997

2009

Volltextzugriff (PDF)

Sequential or concurrent tamoxifen and radiotherapy: to see or not to see--that is the question

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6266-6267

2005

Volltextzugriff (PDF)

Targeted Intraoperative Radiotherapy for Early Breast Cancer

JAMA oncology, 2020-10, Vol.6 (10), p.1636

2020

Volltextzugriff (PDF)

Weight gain after primary surgery for breast cancer--effect of tamoxifen

Breast cancer research and treatment, 1992-01, Vol.22 (2), p.129-132

1992

Volltextzugriff (PDF)

Study design in the evaluation of combined radiotherapy plus chemotherapy

European journal of cancer & clinical oncology, 1990, Vol.26 (7), p.773-775

1990

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

ThemaRadiology, Nuclear Medicine & Medical Imaging

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials

One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

Voluntary breath-hold technique for reducing heart dose in left breast radiotherapy

Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis

Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial

Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial

The UK HeartSpare Study (Stage IB): Randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery

Targeted Intraoperative Radiotherapy for Early Breast Cancer

Targeted radiotherapy for early breast cancer – Authors' reply

Shorter fractionation schedules in breast cancer radiotherapy: Clinical and economic implications

Ductal carcinoma in situ of the breast

Late effects of breast radiotherapy

Hypofractionated Radiotherapy for Breast Cancer

Genome‐wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c‐Kit, CD117) and oestrogen receptor‐α (ERα) in response to therapeutic radiation

Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?

Sequential or concurrent tamoxifen and radiotherapy: to see or not to see--that is the question

Targeted Intraoperative Radiotherapy for Early Breast Cancer

Weight gain after primary surgery for breast cancer--effect of tamoxifen

Study design in the evaluation of combined radiotherapy plus chemotherapy

Aktive Filter

Suchergebnisse filtern